scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.ATV.15.9.1280 |
P8608 | Fatcat ID | release_t6x3nx6ew5a73kgq7h6g7c3czm |
P953 | full work available at URL | https://www.ahajournals.org/doi/full/10.1161/01.ATV.15.9.1280 |
P698 | PubMed publication ID | 7670939 |
P50 | author | Markku Laakso | Q28050161 |
P2093 | author name string | J. Kuusisto | |
Y. A. Kesäniemi | |||
K. Kervinen | |||
L. Mykkänen | |||
P2860 | cites work | Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families | Q27860677 |
Biochemical Journal | Q864221 | ||
Apolipoprotein E: cholesterol transport protein with expanding role in cell biology | Q28294791 | ||
Polymorphism of apolipoprotein E | Q29030664 | ||
Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease | Q29614952 | ||
Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E | Q29615236 | ||
Acute myocardial infarction (AMI) in Finland--baseline data from the FINMONICA AMI register in 1983-1985. | Q31007028 | ||
Cholesterol and mortality. 30 years of follow-up from the Framingham study | Q34183820 | ||
Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years | Q34312337 | ||
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease | Q34662682 | ||
Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study | Q35180405 | ||
Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes | Q35181442 | ||
Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study | Q36888014 | ||
Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease | Q43514952 | ||
Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? | Q43890386 | ||
Apolipoprotein E genotyping using the polymerase chain reaction and allele-specific oligonucleotide probes | Q44605230 | ||
Polymorphism at the apoprotein-E locus in relation to risk of coronary disease | Q44706046 | ||
Genetic influences on age-related change in total cholesterol, low density lipoprotein-cholesterol, and triglyceride levels: longitudinal apolipoprotein E genotype effects | Q44826850 | ||
Smoking and coronary heart disease mortality in the elderly | Q46186010 | ||
Apolipoprotein E polymorphism and Alzheimer's disease. | Q53316388 | ||
Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. | Q53316390 | ||
Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease | Q67521913 | ||
Apolipoprotein E phenotyping: a word of caution | Q67831801 | ||
Asymptomatic hyperglycemia and cardiovascular risk factors in the elderly | Q67973780 | ||
Apolipoprotein E phenotypes, serum lipoproteins and apolipoproteins in angiographically assessed coronary heart disease | Q68053157 | ||
Apolipoprotein E polymorphism and atherosclerosis | Q68126635 | ||
Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes | Q68636790 | ||
Cardiovascular risk factors in the elderly | Q69297978 | ||
Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients | Q69960611 | ||
Disparity between apolipoprotein E phenotypes and genotypes (as determined by polymerase chain reaction and oligonucleotide probes) in patients with non-insulin-dependent diabetes mellitus | Q70143635 | ||
Apolipoprotein E phenotypes in patients with myocardial infarction | Q71274632 | ||
NIDDM and its metabolic control predict coronary heart disease in elderly subjects | Q72080013 | ||
Apolipoprotein E and Alzheimer's disease | Q72529552 | ||
Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus | Q72547648 | ||
Comparison of different analytical and precipitation methods for direct estimation of serum high-density lipoprotein cholesterol | Q72652935 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | heart disease | Q190805 |
phenotype | Q104053 | ||
risk factor | Q1475848 | ||
coronary artery disease | Q844935 | ||
P304 | page(s) | 1280-1286 | |
P577 | publication date | 1995-09-01 | |
P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
P1476 | title | Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects | |
Apolipoprotein E4 Phenotype Is Not an Important Risk Factor for Coronary Heart Disease or Stroke in Elderly Subjects | |||
P478 | volume | 15 |
Q40609823 | A prospective study of the association between APOE genotype and the risk of myocardial infarction among apparently healthy men. |
Q48208048 | APOE does not predict poor outcome 1 year after ischemic stroke |
Q53251385 | APOE genotype in cerebrovascular disease and vascular dementia. |
Q44874657 | Age-dependent interaction of apolipoprotein E gene with eastern birthplace in Finland affects severity of coronary atherosclerosis and risk of fatal myocardial infarction--Helsinki Sudden Death Study |
Q48430523 | Aging and cerebrovascular disease |
Q40497278 | ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population |
Q36804822 | ApoE genotype, cardiovascular risk and responsiveness to dietary fat manipulation |
Q35238425 | Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex |
Q44009086 | Apolipoprotein E and longevity: the Rotterdam Study |
Q48468088 | Apolipoprotein E and the CNS response to injury. |
Q53251390 | Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. |
Q36428621 | Apolipoprotein E gene is related to mortality only in normal weight individuals: the Rotterdam Study |
Q47732476 | Apolipoprotein E genotype in patients with cerebrovascular diseases and its effect on the disease outcome |
Q38448974 | Apolipoprotein E genotypes and cognitive functions in healthy elderly persons |
Q54701449 | Apolipoprotein E polymorphism and stroke in a population from eastern Turkey. |
Q44300579 | Apolipoprotein E polymorphism and stroke subtypes in an Italian cohort. |
Q46665694 | Apolipoprotein E polymorphism is not a predictor for repeated coronary artery bypass surgery |
Q34688023 | Apolipoproteins and aging: emerging mechanisms |
Q48244141 | Association between apolipoprotein E4 and rehabilitation outcome in hospitalized ischemic stroke patients. |
Q30588614 | Association between the apolipoprotein E gene polymorphism and ischemic stroke in Chinese populations: New data and meta-analysis |
Q46521620 | Association of apolipoprotein E genotype and cerebrovascular disease risk factors in a Turkish population |
Q46835614 | Association of apolipoprotein E genotype with early onset of coronary heart disease in Greek men. |
Q80136825 | Association of apolipoprotein E polymorphism with ischemic stroke subtypes in Taiwan |
Q50959234 | Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women. |
Q43906238 | Association of plasma lipid levels with apolipoprotein E polymorphism in Type 2 diabetes |
Q34557702 | Candidate genes as potential links between periodontal and cardiovascular diseases |
Q44111020 | Carotid artery intima-media thickness and brachial artery flow-mediated vasodilation in asymptomatic Japanese male subjects amongst apolipoprotein E phenotypes |
Q73194210 | Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients |
Q37768794 | Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors |
Q47830369 | Genetic risk factors and ischaemic cerebrovascular disease: role of common variation of the genes encoding apolipoproteins and angiotensin-converting enzyme |
Q41725452 | Genetics of stroke--a review |
Q44583853 | LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease |
Q37389564 | Mortality, dementia, and apolipoprotein E genotype in elderly white women in the United States |
Q53215966 | NIA/AIzA Conference on apolipoprotein E genotyping in Alzheimer's disease. Bibliography. |
Q41707869 | Neurobiology of stroke. |
Q37401949 | Nutrigenetics and personalised nutrition: how far have we progressed and are we likely to get there? |
Q44457165 | Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow-up study |
Q41440536 | Prevention of primary event. Ischemic stroke risk detection and reduction. |
Q35060418 | Relationship between ApoE gene polymorphism and coronary heart disease in Gaza Strip |
Q51568132 | Smaller, denser LDL particles are not a risk factor for cardiovascular disease in healthy nonagenarian women of the Cremona Population Study. |
Q28601824 | Structural Neuroimaging Genetics Interactions in Alzheimer's Disease |
Q24803218 | The Siblings With Ischemic Stroke Study (SWISS) protocol |
Q44247540 | The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease |
Q37364340 | The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology |
Q33996158 | The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients |
Q33950398 | The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models |
Q73674062 | The role of apolipoprotein E in cognitive decline after cardiac operation |
Q36698762 | The role of lipid-related genes, aging-related processes, and environment in healthspan |
Search more.